Home > Drug Search >
  • company_query: Broad Institute
  •   > 
Drug Filter
Category:
chemistry (6) biology (21)
Status:
Approved (2) Phase Ⅲ (3) Phase Ⅱ (9) Phase Ⅰ (13)
Clinical Stage:
Pending (1) Active (19) Discontinued (5)
Bio-Type:
Cell therapy (1) Vaccine (14) Recombinant cytokines (1)
Indication:
Acute myeloid Leukemia (AML) (1) Anemia (1) Bladder cancer (1) Breast cancer (2) Hyperkalaemia (1) Avian influenza (1) Endometrial cancer (1) Transplant rejection (1) Gastric cancer (1) Cytomegalovirus infections (1) HBV infection (1) HCV infection (1) HIV infection (1) Melanoma (2) Multiple myeloma (MM) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Parkinson's disease (PD) (1) Prostate cancer (1) Middle East respiratory syndrome coronavirus (1) Zika virus infection (1) Solid tumours (3) Yellow fever (1) Dermatitis (1) Acute enterocolitis (1) Pain (1) Mycosis fungoides (1) Glioblastoma (1) Thrombosis (1) Respiratory syncytial virus infection (1) Neurological disease (1) hematological malignancies (1) Ebola virus disease (EVD) (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top